![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0235.jpg)
Comparison of the two trials of neo-adjuvant chemoth.
USA
GB
Control
CT Control
CT
Chemoth.
Cisplatin: 100 mg/m2
5FU: 1000 mg/m2 D1-5
3 cycles
Cisplatin: 80 mg/m2
5FU: 1000 mg/m2 D1-4
2 cycles
AdenoK. (%)
53
66
R0 (%)
59
62
54
60
Post-operative
mortality (%)
6
6
10
10
2-yr survival (%)
37
35
34
43
3-yr survival (%)
26
23
25
32